Micafungin versus anidulafungin in critically ill patients with invasive candidiasis: a retrospective study

BACKGROUND: In critically ill patients the incidence of invasive fungal infections caused by Candida spp. has increased remarkably. Echinocandins are recommended as initial treatment for invasive fungal infections. The safety and efficacy of micafungin compared to caspofungin is similar, but no comp...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Geest, Patrick J., Hunfeld, Nicole G. M., Ladage, Sophie E., Groeneveld, A. B. Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5025542/
https://www.ncbi.nlm.nih.gov/pubmed/27634140
http://dx.doi.org/10.1186/s12879-016-1825-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5025542/
https://www.ncbi.nlm.nih.gov/pubmed/27634140
http://dx.doi.org/10.1186/s12879-016-1825-3

Ejemplares similares